Published in Lancet Infect Dis on November 01, 2001
Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis (2004) 6.00
Antimicrobial resistance determinants and future control. Emerg Infect Dis (2005) 2.36
Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis (2004) 2.35
Development and evaluation of a chromogenic agar medium for methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2004) 2.22
Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective. Emerg Infect Dis (2002) 1.57
Enhancing patient safety by reducing healthcare-associated infections: the role of discovery and dissemination. Infect Control Hosp Epidemiol (2010) 1.55
Development and assessment of a questionnaire for a descriptive cross-sectional study concerning parents' knowledge, attitudes and practises in antibiotic use in Greece. BMC Infect Dis (2009) 1.06
Synthesis of Schiff bases of naphtha[1,2-d]thiazol-2-amine and metal complexes of 2-(2'-hydroxy)benzylideneaminonaphthothiazole as potential antimicrobial agents. J Zhejiang Univ Sci B (2007) 1.05
Occurrence and relatedness of vancomycin-resistant enterococci in animals, humans, and the environment in different European regions. Appl Environ Microbiol (2005) 1.04
A spatial approach for the epidemiology of antibiotic use and resistance in community-based studies: the emergence of urban clusters of Escherichia coli quinolone resistance in Sao Paulo, Brasil. Int J Health Geogr (2011) 0.98
Cross border comparison of MRSA bacteraemia between The Netherlands and North Rhine-Westphalia (Germany): a cross-sectional study. PLoS One (2012) 0.97
Continuous vs. intermittent cefotaxime administration in patients with chronic obstructive pulmonary disease and respiratory tract infections: pharmacokinetics/pharmacodynamics, bacterial susceptibility and clinical efficacy. Br J Clin Pharmacol (2006) 0.94
Molecular epidemiology of macrolide-resistant isolates of Streptococcus pneumoniae collected from blood and respiratory specimens in Norway. J Clin Microbiol (2005) 0.90
Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus? J Antimicrob Chemother (2011) 0.89
Are there patients with peritonitis who require empiric therapy for enterococcus? Eur J Clin Microbiol Infect Dis (2004) 0.87
The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey. PLoS One (2015) 0.83
Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance. Eur J Clin Microbiol Infect Dis (2012) 0.82
Efficacy and Safety of Procalcitonin-Guided Antibiotic Therapy in Lower Respiratory Tract Infections. Antibiotics (Basel) (2013) 0.78
Identification of cultural determinants of antibiotic use cited in primary care in Europe: a mixed research synthesis study of integrated design "Culture is all around us". BMC Public Health (2015) 0.77
Comparative evaluation of five culture media with triplex PCR assay for detection of methicillin-resistant Staphylococcus aureus. Curr Microbiol (2009) 0.77
Medication errors and adverse drug events in pediatric inpatients. JAMA (2001) 11.34
Rapid dissemination of beta-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N Engl J Med (1990) 4.40
Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science (1999) 4.08
Coagulase-negative staphylococci: role as pathogens. Annu Rev Med (1999) 3.59
Score for Neonatal Acute Physiology: a physiologic severity index for neonatal intensive care. Pediatrics (1993) 3.54
The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin. Infect Immun (1998) 3.44
Isolation and characterization of a capsular polysaccharide adhesin from Staphylococcus epidermidis. J Infect Dis (1988) 3.15
Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med (1990) 2.78
Evaluation of blood culture procedures in a pediatric hospital. J Clin Microbiol (1979) 2.59
Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology. J Pediatr (1986) 2.38
Bacterial colonization of neonates admitted to an intensive care environment. J Pediatr (1978) 2.24
A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics (2001) 2.10
The immunization status of children with spina bifida. Am J Dis Child (1993) 2.07
The person-number systems of Sweden, Norway, Denmark, and Israel. Vital Health Stat 2 (1980) 2.07
Quantitative blood cultures in childhood bacteremia. J Pediatr (1978) 2.05
Fertility after organ-preserving surgery of ectopic pregnancy: results of a multicenter study. Fertil Steril (1997) 2.02
Effect of therapeutic concentrations of nitric oxide on bacterial growth in vitro. Crit Care Med (1998) 2.01
Isolation and characterization of transposon mutants of Staphylococcus epidermidis deficient in capsular polysaccharide/adhesin and slime. Infect Immun (1993) 1.99
The role of pili and capsule in the pathogenesis of neonatal infection with Escherichia coli K1. J Infect Dis (1983) 1.95
Birth weight and illness severity: independent predictors of neonatal mortality. Pediatrics (1993) 1.94
False resistance to imipenem with a microdilution susceptibility testing system. J Clin Microbiol (1991) 1.94
In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol. Antimicrob Agents Chemother (1981) 1.87
Real time patient safety audits: improving safety every day. Qual Saf Health Care (2005) 1.84
Declining severity adjusted mortality: evidence of improving neonatal intensive care. Pediatrics (1998) 1.70
Neonatal therapeutic intervention scoring system: a therapy-based severity-of-illness index. Pediatrics (1992) 1.67
Cephalothin prophylaxis in cardiac valve surgery. A prospective, double-blind comparison of two-day and six-day regimens. J Thorac Cardiovasc Surg (1977) 1.60
Purification and characterization of Haemophilus influenzae pili, and their structural and serological relatedness to Escherichia coli P and mannose-sensitive pili. J Exp Med (1985) 1.60
Nosocomial infections in a neonatal intensive care unit. J Infect Dis (1981) 1.58
Occurrence of nosocomial bloodstream infections in six neonatal intensive care units. Pediatr Infect Dis J (2000) 1.58
Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Infect Immun (1999) 1.57
Pathogenesis and immunity in enterococcal infections. Clin Microbiol Infect (2010) 1.46
Coagulase-negative staphylococcal bacteremia among very low birth weight infants: relation to admission illness severity, resource use, and outcome. Pediatrics (1995) 1.43
Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. N Engl J Med (1987) 1.42
Antibody to the capsular polysaccharide/adhesin protects rabbits against catheter-related bacteremia due to coagulase-negative staphylococci. J Infect Dis (1990) 1.41
Airborne transmission of chickenpox in a hospital. N Engl J Med (1980) 1.39
Endemic nosocomial transmission of Staphylococcus epidermidis bacteremia isolates in a neonatal intensive care unit over 10 years. J Infect Dis (1994) 1.38
Mucoid Escherichia coli in cystic fibrosis. N Engl J Med (1981) 1.37
Protection against endocarditis due to Staphylococcus epidermidis by immunization with capsular polysaccharide/adhesin. Circulation (1991) 1.36
Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillin-placebo. J Infect Dis (1983) 1.32
Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci. Infect Immun (2000) 1.29
Rifampin chemoprophylaxis for household contacts of patients with invasive infections due to Haemophilus influenzae type b. J Pediatr (1981) 1.26
Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent. J Clin Microbiol (1980) 1.24
Quality of care for preschool children with asthma: the role of social factors and practice setting. Pediatrics (1995) 1.23
Extra hospital stay and antibiotic usage with nosocomial coagulase-negative staphylococcal bacteremia in two neonatal intensive care unit populations. Am J Dis Child (1990) 1.21
Infection control in total parenteral nutrition. JAMA (1973) 1.21
Haemophilus influenzae type B meningitis: a contagious disease of children. Br Med J (1980) 1.19
False-positive blood cultures. Association with nonsterile blood collection tubes. JAMA (1976) 1.18
Coagulase-negative staphylococcal bacteremia in the changing neonatal intensive care unit population. Is there an epidemic? JAMA (1987) 1.18
Quality of care at a children's hospital: the parent's perspective. Arch Pediatr Adolesc Med (1999) 1.18
Effect of ampicillin and chloramphenicol alone and in combination on ampicillin-susceptible and -resistant Haemophilus influenzae type B. Antimicrob Agents Chemother (1979) 1.15
Blood proteins do not promote adherence of coagulase-negative staphylococci to biomaterials. Infect Immun (1991) 1.12
Growth of bacteria and fungi in total parenteral nutrition solutions. Am J Surg (1973) 1.12
Reducing infections among women undergoing cesarean section in Colombia by means of continuous quality improvement methods. Arch Intern Med (2001) 1.12
Salmonella bacteremia in the first year of life. J Pediatr (1980) 1.10
The pathogenic role of Staphylococcus epidermidis capsular polysaccharide/adhesin in a low-inoculum rabbit model of prosthetic valve endocarditis. Circulation (1995) 1.08
Nosocomial infection and death in a neonatal intensive care unit. J Infect Dis (1983) 1.08
Fifteen-year experience with bloodstream isolates of coagulase-negative staphylococci in neonatal intensive care. J Clin Microbiol (1988) 1.07
Correlation of netilmicin agar dilution and disk diffusion susceptibilities. Antimicrob Agents Chemother (1977) 1.06
Vaccine potential of poly-1-6 beta-D-N-succinylglucosamine, an immunoprotective surface polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis. J Biotechnol (2000) 1.05
Complications of intravenous therapy with steel needles and Teflon catheters. A comparative study. Am J Med (1981) 1.04
Risk of illness after exposure to a pediatric office. N Engl J Med (1985) 1.04
Ribotyping of Pseudomonas aeruginosa strains isolated from surgical intensive care patients. J Infect Dis (1993) 1.03
Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey. Eur J Clin Microbiol Infect Dis (2009) 1.01
Structure of an antigenic teichoic acid shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Carbohydr Res (1999) 1.00
Reducing the spread of antimicrobial-resistant microorganisms. Control of vancomycin-resistant enterococci. Pediatr Clin North Am (1995) 1.00
Multi-state investigation of the actual disinfection/sterilization of endoscopes in health care facilities. Am J Med (1992) 0.98
Estimating neonatal mortality risk: an analysis of clinicians' judgments. Pediatrics (1994) 0.97
Improved antibiotic usage following introduction of a novel prescription system. JAMA (1981) 0.97
Long-term results following fixation of the vagina on the sacrospinal ligament by the vaginal route (vaginaefixatio sacrospinalis vaginalis). Am J Obstet Gynecol (1981) 0.97
Empyema in children: clinical course and long-term follow-up. Pediatrics (1984) 0.95
Exogenous or endogenous reservoirs of nosocomial Pseudomonas aeruginosa and Staphylococcus aureus infections in a surgical intensive care unit. Intensive Care Med (1993) 0.95
Intravenous lipid emulsions are the major determinant of coagulase-negative staphylococcal bacteremia in very low birth weight newborns. Pediatr Infect Dis J (1998) 0.95
Medication errors in the neonatal intensive care unit: special patients, unique issues. Arch Dis Child Fetal Neonatal Ed (2004) 0.94
An outbreak of Shigella sonnei gastroenteritis on Colorado River raft trips. Am J Epidemiol (1974) 0.94
An international survey of practice variation in the use of antibiotic prophylaxis in cesarean section. Int J Gynaecol Obstet (2001) 0.93
Outcomes of invasive infection due to vancomycin-resistant Enterococcus faecium during a recent outbreak. Infection (2009) 0.91
New microbiological techniques for hospital epidemiology. Eur J Clin Microbiol (1987) 0.90
Discontinuation and non-adherence to endocrine therapy in breast cancer patients: is lack of communication the decisive factor? J Cancer Res Clin Oncol (2014) 0.90
Compliance with hand hygiene practice in pediatric intensive care. Pediatr Crit Care Med (2001) 0.90
Comparison of virulence and colonizing capacity of Escherichia coli K1 and non-K1 strains in neonatal rats. Infect Immun (1982) 0.89
Enterococcal surface protein contributes to persistence in the host but is not a target of opsonic and protective antibodies in Enterococcus faecium infection. J Med Microbiol (2010) 0.87
Editorial: Nosocomial infection--a hazard of newborn intensive care. N Engl J Med (1976) 0.87
Enzymatically labelled nucleic acid (NA) probe assays for detection of Campylobacter spp. in human faecal specimens and in culture. Mol Cell Probes (1990) 0.87
In vitro activity of sodium bisulfite and heparin against staphylococci: new strategies in the treatment of catheter-related infection. J Infect Dis (1993) 0.87
Rapid detection of group A streptococci: comparative performance by nurses and laboratory technologists in pediatric satellite laboratories using three test kits. J Clin Microbiol (1992) 0.86
Implant infections due to enterococci: role of capsular polysaccharides and biofilm. Int J Artif Organs (2005) 0.86
Birth weight and length of stay as determinants of nosocomial coagulase-negative staphylococcal bacteremia in neonatal intensive care unit populations: potential for confounding. Am J Epidemiol (1990) 0.86
Adaptation of the Centers for Disease Control guidelines for the prevention of nosocomial infection in a pediatric intensive care unit in Jakarta, Indonesia. Am J Med (1991) 0.86
In vitro activity of rifampin in combination with oxacillin against Staphylococcus aureus. Antimicrob Agents Chemother (1983) 0.86
Imipenem/cilastatin in acute pulmonary exacerbations of cystic fibrosis. Rev Infect Dis (1985) 0.86
In vitro activity of penicillin and rifampin against group B streptococci. Rev Infect Dis (1983) 0.86
Current issues in central venous catheter infection. Annu Rev Med (1990) 0.85
Attitude of employees of a university clinic to complementary and alternative medicine in oncology. Ann Oncol (2013) 0.84
Comparison of a new, rapid enzyme-linked immunosorbent assay with latex particle agglutination for the detection of Haemophilus influenzae type b infections. J Clin Microbiol (1985) 0.84
Distribution of four capsular serotypes of Enterococcus faecalis among clinical isolates from different geographical origins and infection sites. Infection (2006) 0.84
Hospital infection prevention and control: a model for improving the quality of hospital care in low- and middle-income countries. Infect Control Hosp Epidemiol (1998) 0.83
The effect of a selenium supplementation on the outcome of patients with severe systemic inflammation, burn and trauma. Biofactors (2001) 0.83
Identification of SagA as a novel vaccine target for the prevention of Enterococcus faecium infections. Microbiology (2011) 0.83
Horizontal nonparenteral spread of hepatitis B among children. Ann Intern Med (1981) 0.83
Reducing medical error through systems improvement: the management of febrile infants. Pediatrics (2000) 0.83